MedPath

DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website

Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-07-20
Last Posted Date
2012-07-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
77
Registration Number
NCT01645449
Locations
🇩🇪

Nuvisan Pharma Services GmbH & Co. KG, Neu-Ulm, Germany

Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-06-26
Last Posted Date
2012-06-28
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
100
Registration Number
NCT01627886
Locations
🇮🇳

BA Research India Ltd, Ahmedabad, Gujarat, India

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-06-26
Last Posted Date
2012-09-28
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
48
Registration Number
NCT01627834
Locations
🇮🇳

GVK Biosciences Pvt. Ltd, Ameerpet, Hyderabad, India

Bioequivalence Study of Ropinirole Hydrochloride ER Tablets 2 mg Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-06-26
Last Posted Date
2012-09-28
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
48
Registration Number
NCT01627847
Locations
🇮🇳

GVK Biosciences Pvt. Ltd, Ameerpet, Hyderabad, Andhra Pradesh, India

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-06-18
Last Posted Date
2012-06-25
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
68
Registration Number
NCT01621763
Locations
🇮🇳

Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions

Phase 1
Completed
Conditions
Fasting
Interventions
First Posted Date
2012-06-18
Last Posted Date
2012-06-18
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
68
Registration Number
NCT01621750
Locations
🇮🇳

Lambda Therapeutic Research Ltd, Ahmedabad, Gujrat, India

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-04-20
Last Posted Date
2012-04-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
56
Registration Number
NCT01581866
Locations
🇺🇸

SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-04-20
Last Posted Date
2012-04-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
38
Registration Number
NCT01581879
Locations
🇺🇸

SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-04-20
Last Posted Date
2012-04-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01581775
Locations
🇮🇳

Veeda Clinical Research, India, Ahmedabad, Gujrat, India

Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-04-20
Last Posted Date
2012-04-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
54
Registration Number
NCT01581788
Locations
🇮🇳

Veeda Clinical Research, India, Ahmedabad, Gujrat, India

© Copyright 2025. All Rights Reserved by MedPath